Immune checkpoint inhibitor plus tyrosine kinase inhibitor with or without transarterial chemoembolization for unresectable hepatocellular carcinoma - Pan, Hongyu; Ruan, Minghao; Jin, Riming; Zhang, Jin; Li, Yao; Wu, Dong; Zhang, Lijie; Sun, Wen; Wang, Ruoyu (Frontiers in Oncology, 2025)